Antimicrobial Agents Practice Questions

Q: Which of the following drugs does NOT inhibit bacterial cell wall synthesis?

Spectinomycin. ### Explanation The bacterial cell wall is a complex structure primarily composed of peptidoglycan. Drugs targeting its synthesis are generally bactericidal. **1. Why Spectinomycin is the Correct Answer:** Spectinomycin is an **aminocyclitol antibiotic** (related to aminoglycosides). Its mechanism of action is the **inhibition of protein synthesis** by binding to the **30S ribosomal subunit**. It does not interfere with peptidoglycan synthesis. Historically, its primary clinical use was as an alternative treatment for *Neisseria gonorrhoeae* in patients allergic to penicillin. **2. Why the Other Options are Incorrect:** * **Vancomycin (Option B):** A glycopeptide antibiotic that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing transglycosylation and transpeptidation. * **Aztreonam (Option C):** A **Monobactam** (Beta-lactam) that inhibits cell wall synthesis by binding to **Penicillin-Binding Protein 3 (PBP-3)**, specifically in Gram-negative bacteria. * **Cephalexin (Option D):** A **First-generation Cephalosporin** (Beta-lactam) that inhibits the final transpeptidation step of cell wall synthesis by binding to PBPs. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Cell Wall Inhibitors:** "**V**ery **B**ad **P**eople **C**an't **F**ight" (**V**ancomycin, **B**eta-lactams, **P**hosphomycin, **C**ycloserine, **B**acitracin). * **Spectinomycin vs. Aminoglycosides:** Unlike aminoglycosides, spectinomycin is **bacteriostatic** and does not cause significant ototoxicity or nephrotoxicity. * **Vancomycin Resistance:** Occurs via a change in the binding site from D-Ala-D-Ala to **D-Ala-D-Lac**.

Q: Which of the following antibiotics acts by inhibiting the 30S ribosomal subunit?

Tetracycline. **Explanation:** Protein synthesis inhibitors are a high-yield topic for NEET-PG. To understand the correct answer, one must distinguish between drugs acting on the 30S and 50S ribosomal subunits. **1. Why Tetracycline is Correct:** Tetracyclines (and Aminoglycosides) specifically target the **30S ribosomal subunit**. Tetracycline acts by binding reversibly to the 30S subunit, preventing the attachment of aminoacyl-tRNA to the 'A' site on the mRNA-ribosome complex. This halts the addition of amino acids to the growing peptide chain, making it **bacteriostatic**. **2. Why the Other Options are Incorrect:** * **Chloramphenicol:** Acts on the **50S subunit** by inhibiting the enzyme peptidyltransferase, preventing peptide bond formation. * **Erythromycin (Macrolide):** Acts on the **50S subunit** by binding to the 23S rRNA, which inhibits the translocation step (movement of tRNA from A to P site). * **Penicillin:** This is a Beta-lactam antibiotic. It does not inhibit protein synthesis; instead, it inhibits **cell wall synthesis** by binding to Penicillin-Binding Proteins (PBPs) and preventing peptidoglycan cross-linking. **Clinical Pearls for NEET-PG:** * **Mnemonic for 30S vs 50S:** "**Buy AT 30, CEL at 50**" * **30S:** **A**minoglycosides (Bactericidal), **T**etracyclines (Bacteriostatic). * **50S:** **C**hloramphenicol, **E**rythromycin (Macrolides), **L**inezolid/Clindamycin. * **Tetracycline Side Effects:** Fanconi syndrome (expired tetracyclines), tooth discoloration, and phototoxicity. * **Aminoglycosides:** The only protein synthesis inhibitors that are **bactericidal** and cause irreversible inhibition of the 30S subunit.

Q: Aminoglycosides affect which part of the cochlea?

Outer hair cells in the basal area. **Explanation:** Aminoglycosides (e.g., Gentamicin, Amikacin, Neomycin) are notorious for their **ototoxicity**, which can manifest as either vestibular or cochlear damage. **Why Option A is correct:** The primary site of damage in aminoglycoside-induced cochleotoxicity is the **Outer Hair Cells (OHCs)** of the **Organ of Corti**. These cells are more susceptible than inner hair cells because they accumulate the drug more readily. The damage typically begins at the **basal turn** of the cochlea. Since the basal area is responsible for processing **high-frequency sounds**, patients initially present with high-frequency hearing loss before it progresses to lower frequencies (apical area). **Why other options are incorrect:** * **Options B & D:** While Inner Hair Cells (IHCs) can eventually be affected in severe, prolonged toxicity, the **Outer Hair Cells** are always the primary and initial target. * **Options C & D:** The **apical area** of the cochlea processes low-frequency sounds. Aminoglycoside damage is characteristically **descending**, meaning it starts at the base (high frequency) and moves toward the apex (low frequency) only as toxicity worsens. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Aminoglycosides generate reactive oxygen species (ROS) in the inner ear, leading to apoptosis of hair cells. * **Specific Drugs:** **Neomycin, Amikacin, and Kanamycin** are primarily **cochleotoxic**, whereas **Streptomycin and Gentamicin** are primarily **vestibulotoxic**. * **Risk Factors:** Toxicity is increased by concurrent use of **Loop Diuretics** (e.g., Furosemide), which increases the concentration of aminoglycosides in the endolymph. * **Monitoring:** High-frequency audiometry is the most sensitive method for early detection of ototoxicity.

Q: Chloroquine is given as a 600 mg loading dose because:

It has increased tissue binding.. Explanation: The correct answer is **C. It has increased tissue binding.** Chloroquine is characterized by an exceptionally large **Volume of Distribution ($V_d$)**, often exceeding 10,000–20,000 L. This is because the drug extensively binds to tissues, particularly melanin-rich tissues (retina), liver, spleen, and lungs. When a drug has high tissue binding, it takes a significant amount of time for the plasma concentration to reach a therapeutic steady state. A **loading dose** (600 mg base) is administered to rapidly saturate these tissue binding sites and ensure that an effective concentration is achieved in the blood to act against the erythrocytic stages of *Plasmodium* [1]. **Analysis of Incorrect Options:** * **A. It is rapidly absorbed:** While Chloroquine is indeed well-absorbed from the GI tract, rapid absorption is an indication for a fast onset of action, not a reason for a high loading dose. * **B. It is rapidly metabolized:** Chloroquine is metabolized slowly by the liver (CYP enzymes). If a drug were metabolized rapidly, it would require frequent maintenance doses, not necessarily a large loading dose. * **D. It is rapidly eliminated:** Chloroquine has a very long elimination half-life ($t_{1/2}$) of about 30–60 days due to its slow release from tissue stores. Rapid elimination would necessitate a continuous infusion or frequent dosing. **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits heme polymerase (biocrystallization), leading to the accumulation of toxic heme in the parasite. * **Drug of Choice:** Still the DOC for sensitive *P. falciparum* and *P. vivax* (erythrocytic stages). * **Adverse Effects:** Pruritus (common in Africans), bull’s eye maculopathy (retinopathy), and QTc prolongation. * **Safe in Pregnancy:** Chloroquine is considered the safest antimalarial during pregnancy.

Q: Levamisole is used for all except which of the following?

Immunosuppressant in high doses. **Explanation:** Levamisole is a synthetic imidazothiazole derivative primarily used as an anthelmintic and an immunomodulator. **Why Option D is correct:** Levamisole acts as an **immunostimulant**, not an immunosuppressant. It restores depressed T-cell function and enhances phagocytosis. While it was historically used in conditions like rheumatoid arthritis or as an adjuvant in colon cancer, it does not suppress the immune system even at high doses. In fact, high doses or prolonged use are associated with serious adverse effects like **agranulocytosis** and **levamisole-induced vasculopathy**. **Why the other options are incorrect:** * **Option A:** Levamisole is highly effective against *Ascaris lumbricoides*. A **single dose** (150 mg for adults) achieves a high cure rate (approx. 90%) by causing rapid expulsion of the worms. * **Option B:** It is a well-known **immunomodulator** that "normalizes" the immune response rather than suppressing it. It was the first drug used to boost host defense in malignancies. * **Option C:** Its mechanism of action involves acting as a **nicotinic acetylcholine receptor agonist**. This causes persistent depolarization, leading to **spastic paralysis** of the worm, which is then expelled by peristalsis. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Levamisole is a secondary drug for Ascariasis (Albendazole/Mebendazole are preferred). * **Side Effect:** Agranulocytosis is a rare but classic board-exam side effect. * **Veterinary Use:** It is frequently used as a dewormer in livestock. * **Adulterant:** It is commonly used as a cutting agent in illicit **cocaine**, leading to characteristic retiform purpura and skin necrosis in users.

Q: A 26-year-old patient presents with suspected pneumococcal meningitis. CSF culture is sent for antibiotic sensitivity. Which empirical antibiotic should be given until culture sensitivity results are available?

Cefotaxime plus vancomycin. **Explanation:** The management of bacterial meningitis is a medical emergency requiring immediate empirical therapy. The choice of antibiotics is guided by the most likely pathogens and current resistance patterns. **Why D is correct:** In a 26-year-old (adult), the most common cause of bacterial meningitis is *Streptococcus pneumoniae*. Due to the rising prevalence of **Penicillin-resistant Streptococcus pneumoniae (PRSP)** and Cephalosporin-resistant strains, monotherapy is no longer recommended. * **Cefotaxime (or Ceftriaxone):** A 3rd generation cephalosporin that provides excellent CSF penetration and coverage against most pneumococci and *Neisseria meningitidis*. * **Vancomycin:** Added to the empirical regimen to cover highly penicillin-resistant pneumococci. This combination ensures synergistic and comprehensive coverage until sensitivities are known. **Why other options are incorrect:** * **A. Penicillin G:** Once the drug of choice, it is no longer used empirically due to widespread high-level resistance in *S. pneumoniae*. * **B. Ceftriaxone plus metronidazole:** Metronidazole is used for anaerobic coverage (e.g., brain abscess), but it is not part of the standard empirical protocol for community-acquired meningitis. * **C. Doxycycline:** This is a bacteriostatic drug with poor CSF penetration; it is not indicated for acute bacterial meningitis. **High-Yield Clinical Pearls for NEET-PG:** 1. **Steroids:** Dexamethasone should be administered **before or with the first dose** of antibiotics to reduce neurological sequelae (hearing loss/edema) caused by inflammatory lysis of bacteria. 2. **Age-specific coverage:** If the patient were >50 years or immunocompromised, **Ampicillin** must be added to cover *Listeria monocytogenes*. 3. **Prophylaxis:** Rifampicin is the drug of choice for chemoprophylaxis in close contacts of *Meningococcal* meningitis.

Q: Pentamidine therapy causes all the following findings, EXCEPT?

None of the above. **Explanation:** Pentamidine is a second-line agent used for the treatment and prophylaxis of *Pneumocystis jirovecii* pneumonia (PCP), particularly in patients who cannot tolerate Trimethoprim-Sulfamethoxazole (TMP-SMX). The correct answer is **"None of the above"** because Pentamidine therapy, especially when administered via the **aerosolized (inhaled) route**, is paradoxically associated with all the findings listed in options A, B, and C. 1. **Upper lobe infiltrates (Option A):** When Pentamidine is inhaled, the drug distribution is often poor in the lung apices due to gravity and ventilation-perfusion mismatch. Consequently, prophylaxis fails in the upper lobes, leading to localized PCP recurrences presenting as upper lobe infiltrates (mimicking tuberculosis). 2. **Cavitation (Option B):** Pentamidine-treated patients often show atypical radiological presentations. The inflammatory response and tissue necrosis associated with breakthrough infections can lead to thin-walled cysts (pneumatoceles) or cavitary lesions, increasing the risk of spontaneous pneumothorax. 3. **Extrathoracic manifestations (Option C):** Aerosolized Pentamidine provides only local protection [1]. It does not reach systemic circulation in therapeutic levels, allowing *P. jirovecii* to disseminate to extrapulmonary sites such as the spleen, liver, bone marrow, and lymph nodes. **High-Yield Clinical Pearls for NEET-PG:** * **Systemic Side Effects (IV Pentamidine):** Nephrotoxicity, severe hypotension (if infused rapidly), and pancreatic toxicity (initial hypoglycemia followed by secondary Diabetes Mellitus due to islet cell damage). * **Aerosolized Side Effects:** Bronchospasm (can be pre-treated with β2-agonists) [1]. * **Drug of Choice for PCP:** TMP-SMX remains the gold standard for both treatment and prophylaxis. Pentamidine is reserved for sulfa-allergic patients or treatment failure.

Q: What is the mechanism of action of ciprofloxacin in Gram-negative bacteria?

Inhibition of DNA gyrase. **Ciprofloxacin** belongs to the Fluoroquinolone class of antibiotics. Its primary mechanism involves the inhibition of bacterial DNA synthesis [3].1. **Why Option C is Correct:**In **Gram-negative bacteria**, the primary target of ciprofloxacin is **DNA gyrase (Topoisomerase II)** [1, 2, 3]. DNA gyrase is responsible for introducing negative supercoils into the DNA molecule, which helps relieve the torsional strain (positive supercoiling) that develops ahead of the replicating fork [1, 2]. By inhibiting the A-subunit of DNA gyrase, ciprofloxacin prevents DNA replication and transcription, leading to bacterial cell death (bactericidal action) [1].2. **Why Other Options are Incorrect:** * **Option A:** Inhibition of mycolic acid synthesis is the mechanism of **Isoniazid (INH)**, used in the treatment of tuberculosis. * **Option B:** While fluoroquinolones also inhibit **Topoisomerase IV**, this is the *primary* target in **Gram-positive bacteria** (e.g., *S. aureus*). In Gram-negative organisms like *E. coli*, DNA gyrase is the more sensitive target [1]. * **Option D:** Helicase is responsible for unwinding the DNA double helix, but it is not the target of fluoroquinolones.**High-Yield Clinical Pearls for NEET-PG:** * **Spectrum:** Ciprofloxacin is highly active against aerobic Gram-negative bacilli, including *Pseudomonas aeruginosa*. * **Resistance:** Occurs via mutations in the *gyrA* gene or through "Qnr proteins" (plasmid-mediated). * **Adverse Effects:** Most characteristic are **tendon rupture/tendonitis** (especially in elderly or those on steroids) and **QT interval prolongation**. * **Contraindication:** Generally avoided in children and pregnancy due to the risk of **arthropathy** (cartilage damage).

Q: What is the drug of choice for the treatment of meningococcal meningitis?

Ceftriaxone. **Explanation:** **Ceftriaxone (Option B)** is the drug of choice for meningococcal meningitis caused by *Neisseria meningitidis*. The underlying medical concept relies on its excellent **cerebrospinal fluid (CSF) penetration**, long half-life (allowing once or twice daily dosing), and high potency against common meningeal pathogens. While penicillin G was historically the gold standard, the rise of penicillin-resistant strains has made third-generation cephalosporins like Ceftriaxone the empirical and definitive treatment of choice. **Analysis of Incorrect Options:** * **Piperacillin (Option A):** This is an antipseudonal penicillin. While it has a broad spectrum, it is primarily used for *Pseudomonas aeruginosa* infections and does not achieve optimal therapeutic levels in the CSF compared to Ceftriaxone. * **Ampicillin (Option C):** This is the drug of choice for *Listeria monocytogenes* meningitis (common in neonates and the elderly) but is not the primary choice for meningococcus due to potential resistance. * **Meropenem (Option D):** While it has excellent CSF penetration and covers *N. meningitidis*, it is reserved for multi-drug resistant (MDR) cases or patients with severe beta-lactam allergies (cephalosporin resistance). It is not the first-line agent. **High-Yield Clinical Pearls for NEET-PG:** * **Chemoprophylaxis:** For close contacts of a patient with meningococcal meningitis, **Rifampicin** is the drug of choice (alternatives: Ciprofloxacin or Ceftriaxone). * **Empirical Therapy:** In adults, the standard empirical regimen is **Ceftriaxone + Vancomycin** (to cover resistant *S. pneumoniae*). * **Steroids:** Dexamethasone should be administered just before or with the first dose of antibiotics to reduce neurological complications (primarily in *H. influenzae* and *S. pneumoniae*).

Question 1

Which of the following drugs does NOT inhibit bacterial cell wall synthesis?

Accepted Answer

Spectinomycin

Answer

Vancomycin

Answer

Aztreonam

Answer

Cephalexin

Question 2

Which of the following antibiotics acts by inhibiting the 30S ribosomal subunit?

Accepted Answer

Tetracycline

Answer

Chloramphenicol

Answer

Erythromycin

Answer

Penicillin

Question 3

Aminoglycosides affect which part of the cochlea?

Accepted Answer

Outer hair cells in the basal area

Answer

Inner hair cells in the basal area

Answer

Outer hair cells in the apical area

Answer

Inner hair cells in the apical area

Question 4

Chloroquine is given as a 600 mg loading dose because:

Accepted Answer

It has increased tissue binding.

Answer

It is rapidly absorbed.

Answer

It is rapidly metabolized.

Answer

It is rapidly eliminated.

Question 5

Levamisole is used for all except which of the following?

Accepted Answer

Immunosuppressant in high doses

Answer

Single dose in ascariasis

Answer

Immunostimulant

Answer

Paralysis of worms by depolarization

Question 6

A 26-year-old patient presents with suspected pneumococcal meningitis. CSF culture is sent for antibiotic sensitivity. Which empirical antibiotic should be given until culture sensitivity results are available?

Accepted Answer

Cefotaxime plus vancomycin

Answer

Penicillin G

Answer

Ceftriaxone plus metronidazole

Answer

Doxycycline

Question 7

Pentamidine therapy causes all the following findings, EXCEPT?

Accepted Answer

None of the above

Answer

Upper lobe infiltrates

Answer

Cavitation

Answer

Extrathoracic manifestations

Question 8

Folic acid metabolism is inhibited by which of the following agents?

Accepted Answer

Sulfonamides, Methotrexate, and Trimethoprim

Answer

Sulfonamides, Trimethoprim, and Nitrous oxide

Answer

Methotrexate, Nitrous oxide, and 5-Flucytosine

Answer

Sulfonamides, 5-Flucytosine, and Nitrous oxide

Question 9

What is the mechanism of action of ciprofloxacin in Gram-negative bacteria?

Accepted Answer

Inhibition of DNA gyrase

Answer

Inhibition of mycolic acid synthesis

Answer

Inhibition of topoisomerase IV

Answer

Inhibition of helicase

Question 10

What is the drug of choice for the treatment of meningococcal meningitis?

Accepted Answer

Ceftriaxone

Answer

Piperacillin

Answer

Ampicillin

Answer

Meropenem

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?